scholarly article | Q13442814 |
P50 | author | L. Darryl Quarles | Q55873742 |
Min Pi | Q56438767 | ||
Abby L Parrill | Q92260429 | ||
P2860 | cites work | Endocrine regulation of energy metabolism by the skeleton | Q22337453 |
The dynamic and elusive membrane estrogen receptor-alpha | Q24294700 | ||
Pharmacological Reviews | Q2085079 | ||
Cloning and characterization of a specific coactivator, ARA70, for the androgen receptor in human prostate cells | Q24314557 | ||
Cloning and tissue expression of two putative steroid membrane receptors | Q24323333 | ||
The Protein Data Bank | Q24515306 | ||
Identification of a novel extracellular cation-sensing G-protein-coupled receptor | Q24548217 | ||
Cloning, expression, and characterization of a membrane progestin receptor and evidence it is an intermediary in meiotic maturation of fish oocytes | Q24553347 | ||
Steroid-induced androgen receptor-oestradiol receptor beta-Src complex triggers prostate cancer cell proliferation | Q24631073 | ||
The 2.6 angstrom crystal structure of a human A2A adenosine receptor bound to an antagonist | Q24654563 | ||
High-resolution crystal structure of an engineered human beta2-adrenergic G protein-coupled receptor | Q24657484 | ||
Crystal structure of rhodopsin: A G protein-coupled receptor | Q27625972 | ||
Structure of a beta1-adrenergic G-protein-coupled receptor | Q27651011 | ||
Klotho converts canonical FGF receptor into a specific receptor for FGF23 | Q28272505 | ||
MIF is a noncognate ligand of CXC chemokine receptors in inflammatory and atherogenic cell recruitment | Q28298072 | ||
Estrogen-induced activation of Erk-1 and Erk-2 requires the G protein-coupled receptor homolog, GPR30, and occurs via trans-activation of the epidermal growth factor receptor through release of HB-EGF | Q29615227 | ||
Osteomimetic properties of prostate cancer cells: a hypothesis supporting the predilection of prostate cancer metastasis and growth in the bone environment | Q30304016 | ||
Selective androgen receptor modulators: in pursuit of tissue-selective androgens. | Q30357822 | ||
GPRC6A null mice exhibit osteopenia, feminization and metabolic syndrome | Q30440683 | ||
Molecular cloning, expression, and sequence analysis of GPRC6A, a novel family C G-protein-coupled receptor | Q31078454 | ||
Rapid effects of androgens in macrophages. | Q31103826 | ||
The human prostate cancer cell line LNCaP bears functional membrane testosterone receptors that increase PSA secretion and modify actin cytoskeleton | Q31106606 | ||
Functional testosterone receptors in plasma membranes of T cells. | Q31942621 | ||
The roles of androgen receptors and androgen-binding proteins in nongenomic androgen actions | Q33961658 | ||
Studies on the pathogenesis of the pseudohermaphroditism in the mouse with testicular feminization | Q34071470 | ||
Multiple actions of steroid hormones--a focus on rapid, nongenomic effects | Q34106409 | ||
Rapid actions of steroid receptors in cellular signaling pathways. | Q34135517 | ||
Generation and characterization of androgen receptor knockout (ARKO) mice: an in vivo model for the study of androgen functions in selective tissues | Q34159764 | ||
Testosterone supplementation therapy for older men: potential benefits and risks | Q34171397 | ||
Deorphanization of GPRC6A: a promiscuous L-alpha-amino acid receptor with preference for basic amino acids | Q34373048 | ||
Transcriptional regulation by steroid hormones | Q34390608 | ||
Testosterone and prostate cancer: an historical perspective on a modern myth | Q34552217 | ||
Prostate cancer risk in testosterone-treated men. | Q34582772 | ||
Cellular functions of plasma membrane estrogen receptors | Q34605439 | ||
Testosterone signaling in T cells and macrophages | Q34605474 | ||
Inhibition of luteinizing hormone secretion by testosterone in men requires aromatization for its pituitary but not its hypothalamic effects: evidence from the tandem study of normal and gonadotropin-releasing hormone-deficient men | Q34724175 | ||
Nongenomic actions of steroid hormones | Q35038285 | ||
Impaired osteoblast function in GPRC6A null mice | Q35156186 | ||
Nongenomic steroid action: controversies, questions, and answers | Q35169916 | ||
Pharmacological characterization of mouse GPRC6A, an L-alpha-amino-acid receptor modulated by divalent cations | Q36052549 | ||
Dynamic combinatorial networks in nuclear receptor-mediated transcription | Q36217187 | ||
Parathyroid cell growth in patients with advanced secondary hyperparathyroidism: vitamin D receptor, calcium sensing receptor, and cell cycle regulating factors | Q36234302 | ||
Progestin, estrogen and androgen G-protein coupled receptors in fish gonads. | Q36313633 | ||
Androgen cell signaling pathways involved in neuroprotective actions. | Q36713951 | ||
Sex steroid effects at target tissues: mechanisms of action | Q36747053 | ||
Testosterone signaling through internalizable surface receptors in androgen receptor-free macrophages | Q36915833 | ||
Agonists and allosteric modulators of the calcium-sensing receptor and their therapeutic applications | Q37602947 | ||
Influence of testosterone and a novel SARM on gene expression in whole blood of Macaca fascicularis. | Q39980990 | ||
Ca2+ oscillations induced by testosterone enhance neurite outgrowth. | Q40322737 | ||
Neurosteroids and GABAA receptor function. | Q40372468 | ||
Cloning and characterization of a family C orphan G-protein coupled receptor | Q40437548 | ||
Nongenomic androgen activation of phosphatidylinositol 3-kinase/Akt signaling pathway in MC3T3-E1 osteoblasts. | Q40549421 | ||
Role of putative membrane receptors in the effect of androgens on human vascular cell growth | Q40601765 | ||
Polycystin-1 transforms the cAMP growth-responsive phenotype of M-1 cells | Q40789860 | ||
The human membrane progesterone receptor gene: genomic structure and promoter analysis | Q43791168 | ||
Rapid nongenomic E2 effects on p42/p44 MAPK, activator protein-1, and cAMP response element binding protein in rat white adipocytes | Q43893288 | ||
Dehydroepiandrosterone activates endothelial cell nitric-oxide synthase by a specific plasma membrane receptor coupled to Galpha(i2,3). | Q43948886 | ||
Androgen Stimulates Matrix Metalloproteinase-2 Expression in Human Prostate Cancer | Q44405057 | ||
Rapid nongenomic effects of aldosterone on human forearm vasculature | Q44513151 | ||
Testosterone stimulates intracellular calcium release and mitogen-activated protein kinases via a G protein-coupled receptor in skeletal muscle cells | Q44514623 | ||
Signaling Cross-talk from Gβ4 Subunit to Elk-1 in the Rapid Action of Androgens | Q44645478 | ||
Biochemical characterization of a membrane androgen receptor in the ovary of the atlantic croaker (Micropogonias undulatus). | Q44777314 | ||
Circulating bioactive androgens in midlife women. | Q45975553 | ||
Testosterone impairs insulin sensitivity in 3T3-L1 adipocytes and the related nongenomic mechanisms | Q46293626 | ||
Androgen receptor signaling intensity is a key factor in determining the sensitivity of prostate cancer cells to selenium inhibition of growth and cancer-specific biomarkers | Q46601641 | ||
Issues in testosterone replacement in older men. | Q46865270 | ||
Binding of 5 alpha-dihydroprogesterone and other progestins to female rat anterior pituitary nuclear extracts | Q48381193 | ||
Nature of functional estrogen receptors at the plasma membrane. | Q50732202 | ||
Acute sex steroid withdrawal reduces insulin sensitivity in healthy men with idiopathic hypogonadotropic hypogonadism. | Q51464753 | ||
Changes in serum testosterone levels following acute LH treatment in immature and mature rats | Q68889955 | ||
Pertussis toxin-catalyzed ADP-ribosylation of transducin. Cysteine 347 is the ADP-ribose acceptor site | Q69847015 | ||
Vasodilation to acetylcholine in primary and secondary forms of human hypertension | Q70744736 | ||
Androgens increase intracellular calcium concentration and inositol 1,4,5-trisphosphate and diacylglycerol formation via a pertussis toxin-sensitive G-protein | Q72287663 | ||
Regulation of aromatase activity of cultured adipose stromal cells by catecholamines and adrenocorticotropin | Q72742731 | ||
Simultaneous detection and functional response of testosterone and estradiol receptors in osteoblast plasma membranes | Q74342755 | ||
P433 | issue | 51 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | cell biology | Q7141 |
P304 | page(s) | 39953-39964 | |
P577 | publication date | 2010-10-13 | |
P1433 | published in | Journal of Biological Chemistry | Q867727 |
P1476 | title | GPRC6A mediates the non-genomic effects of steroids | |
GPRC6A Mediates the Non-genomic Effects of Steroids | |||
P478 | volume | 285 |
Q35018117 | A novel role for ecdysone in Drosophila conditioned behavior: linking GPCR-mediated non-canonical steroid action to cAMP signaling in the adult brain |
Q37365294 | A systems biology preview of the relationships between mineral and metabolic complications in chronic kidney disease. |
Q100660457 | ARe we there yet? Understanding androgen receptor signaling in breast cancer |
Q92800793 | Acute testosterone administration does not affect muscle anabolism |
Q38032225 | Amino acid sensing in the gastrointestinal tract |
Q38690915 | An overview of osteocalcin progress |
Q35559000 | Anabolic androgenic steroids and intracellular calcium signaling: a mini review on mechanisms and physiological implications |
Q26750866 | Androgen Receptor Structure, Function and Biology: From Bench to Bedside |
Q55344917 | Androgen Regulation of the Mesocorticolimbic System and Executive Function. |
Q90045754 | Androgen dihydrotestosterone (DHT) promotes the bladder cancer nuclear AR-negative cell invasion via a newly identified membrane androgen receptor (mAR-SLC39A9)-mediated Gαi protein/MAPK/MMP9 intracellular signaling |
Q55357541 | Androgen-Induced Immunosuppression. |
Q57800002 | Androgen-dependent immune modulation in parasitic infection |
Q90208860 | Androgens augment pulmonary responses to ozone in mice |
Q30360857 | Antagonizing effects of membrane-acting androgens on the eicosanoid receptor OXER1 in prostate cancer |
Q36211542 | Antiandrogen gold nanoparticles dual-target and overcome treatment resistance in hormone-insensitive prostate cancer cells. |
Q33850663 | CRISPR/Cas9 targeting of GPRC6A suppresses prostate cancer tumorigenesis in a human xenograft model |
Q52570089 | Computationally identified novel agonists for GPRC6A. |
Q34642934 | Endocrine regulation of male fertility by the skeleton |
Q38067511 | Endogenous metabolites as ligands for G protein-coupled receptors modulating risk factors for metabolic and cardiovascular disease |
Q36911581 | Evidence for Osteocalcin Binding and Activation of GPRC6A in β-Cells |
Q47307701 | Fertility impairment with defective spermatogenesis and steroidogenesis in male zebrafish lacking androgen receptor |
Q37269322 | Functional characterization and anti-cancer action of the clinical phase II cardiac Na+/K+ ATPase inhibitor istaroxime: in vitro and in vivo properties and cross talk with the membrane androgen receptor. |
Q37022301 | G protein-coupled receptor GPR160 is associated with apoptosis and cell cycle arrest of prostate cancer cells |
Q22305605 | G protein-coupled receptors: extranuclear mediators for the non-genomic actions of steroids |
Q50146100 | GPCR6A is a Molecular Target for the Natural Products Gallate and EGCG in Green Tea. |
Q36439458 | GPRC6A mediates the effects of L-arginine on insulin secretion in mouse pancreatic islets |
Q34193432 | GPRC6A regulates prostate cancer progression |
Q37613880 | GPRC6A: Jack of all metabolism (or master of none). |
Q34675214 | Gene expression profile analysis identifies metastasis and chemoresistance-associated genes in epithelial ovarian carcinoma cells |
Q38725785 | Genetic Variations in the Human G Protein-coupled Receptor Class C, Group 6, Member A (GPRC6A) Control Cell Surface Expression and Function |
Q34650062 | Genome-wide testing of putative functional exonic variants in relationship with breast and prostate cancer risk in a multiethnic population |
Q39395252 | Genomic and non-genomic effects of androgens in the cardiovascular system: clinical implications |
Q92510451 | Human GPRC6A Mediates Testosterone-Induced Mitogen-Activated Protein Kinases and mTORC1 Signaling in Prostate Cancer Cells |
Q97418728 | Humanized GPRC6AKGKY is a gain-of-function polymorphism in mice |
Q24605072 | International Union of Basic and Clinical Pharmacology. LXXXVIII. G protein-coupled receptor list: recommendations for new pairings with cognate ligands |
Q38714201 | Intracrine androgen biosynthesis in renal cell carcinoma |
Q50930149 | Long-term oral administration of osteocalcin induces insulin resistance in male mice fed a high-fat, high-sucrose diet. |
Q64052864 | Metabolic and skeletal homeostasis are maintained in full locus GPRC6A knockout mice |
Q26864827 | Minireview: Nutrient sensing by G protein-coupled receptors |
Q26862997 | Multiligand specificity and wide tissue expression of GPRC6A reveals new endocrine networks |
Q35897933 | Murine GPRC6A Mediates Cellular Responses to L-Amino Acids, but Not Osteocalcin Variants |
Q41532436 | N-glycosylation and disulfide bonding affects GPRC6A receptor expression, function, and dimerization |
Q33572134 | Novel bone endocrine networks integrating mineral and energy metabolism |
Q47560656 | Nuclear Androgen Receptor Regulates Testes Organization and Oocyte Maturation in Zebrafish |
Q38978340 | Nuclear receptors outside the nucleus: extranuclear signalling by steroid receptors |
Q104459009 | OXER1 and RACK1-associated pathway: a promising drug target for breast cancer progression |
Q38611641 | Osteocalcin-dependent regulation of glucose metabolism and fertility: Skeletal implications for the development of insulin resistance |
Q46778239 | Oxidative stress-associated senescence in dermal papilla cells of men with androgenetic alopecia |
Q28068298 | Recent Advances in Understanding Amino Acid Sensing Mechanisms that Regulate mTORC1 |
Q26764871 | Regulation of mTORC1 by growth factors, energy status, amino acids and mechanical stimuli at a glance |
Q35832494 | Relationship of testosterone and osteocalcin levels during growth |
Q34291380 | Replication and fine mapping for association of the C2orf43, FOXP4, GPRC6A and RFX6 genes with prostate cancer in the Chinese population |
Q94461819 | Role of GPRC6A in Regulating Hepatic Energy Metabolism in Mice |
Q92132730 | SHBG141-161 Domain-Peptide Stimulates GPRC6A-Mediated Response in Leydig and β-Langerhans cell lines |
Q38256290 | Sexual dimorphism in immunity: improving our understanding of vaccine immune responses in men. |
Q45976988 | Specificity out of clutter: a hypothetical role of G protein-coupled receptors in the non-genomic effect of steroids. |
Q36243548 | Stable Isotope Labeling with Amino Acids (SILAC)-Based Proteomics of Primary Human Kidney Cells Reveals a Novel Link between Male Sex Hormones and Impaired Energy Metabolism in Diabetic Kidney Disease |
Q36331791 | Structural and Functional Evidence for Testosterone Activation of GPRC6A in Peripheral Tissues |
Q37666748 | TCF21 is related to testis growth and development in broiler chickens |
Q22306017 | Targeting membrane androgen receptors in tumors |
Q38121742 | Testicular function and bone metabolism--beyond testosterone |
Q43171849 | Testosterone and secondary hypertension: new pieces to the puzzle. |
Q34355579 | Testosterone stimulates Duox1 activity through GPRC6A in skin keratinocytes |
Q58707374 | The Divergent Function of Androgen Receptor in Breast Cancer; Analysis of Steroid Mediators and Tumor Intracrinology |
Q98735476 | The Effects of Androgens on T Cells: Clues to Female Predominance in Autoimmune Liver Diseases? |
Q38137171 | The GPCR, class C, group 6, subtype A (GPRC6A) receptor: from cloning to physiological function |
Q50851917 | The GPRC6A receptor displays constitutive internalization and sorting to the slow recycling pathway. |
Q44176174 | The L-α-amino acid receptor GPRC6A is expressed in the islets of Langerhans but is not involved in L-arginine-induced insulin release |
Q35048801 | The TRPM8 protein is a testosterone receptor: II. Functional evidence for an ionotropic effect of testosterone on TRPM8 |
Q38195010 | The actin cytoskeleton in rapid steroid hormone actions |
Q37085318 | The skeleton gets a (reproductive) life |
Q34167106 | Understanding extranuclear (nongenomic) androgen signaling: what a frog oocyte can tell us about human biology |
Q35130517 | Unraveling the mechanisms underlying the rapid vascular effects of steroids: sorting out the receptors and the pathways. |
Search more.